Last reviewed · How we verify
NCT03229668
Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Urological Surgical Operations
Phase 2, PHASE3 trial testing Placebo oral capsule in Pregabalin on Catheter Related Bladder Discomfort in 78 participants. Completed in 20 February 2020.
31 December 2019
Quick facts
| Lead sponsor | Saint Savvas Anticancer Hospital |
|---|---|
| Phase | Phase 2, PHASE3 |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | prevention |
| Enrollment | 78 |
| Start date | 28 July 2017 |
| Primary completion | 31 December 2019 |
| Estimated completion | 20 February 2020 |
| Sites | 2 locations across Greece |
Drugs / interventions tested
- Placebo oral capsule
- Pregabalin Oral Capsule [Lyrica] 75mg — full drug profile →
- Pregabalin Oral Capsule [Lyrica] 150 mg — full drug profile →
Conditions studied
- Pregabalin on Catheter Related Bladder Discomfort — all drugs for Pregabalin on Catheter Related Bladder Discomfort →
Sponsor
Saint Savvas Anticancer Hospital
Who can join
Adults 45 to 85, any sex, with Pregabalin on Catheter Related Bladder Discomfort. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this study is to assess the effect of pregabalin administration on catheter-related bladder discomfort (CRBD). The study group includes patients that are about to be subjected to urological operations because of the high incidence of CRBD observed in this kind of surgical population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03229668
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Pregabalin Oral Capsule [Lyrica] 75mg
Trials testing the same drug.
- NCT03232021 — Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations · Phase 2, PHASE3 · withdrawn
Other Saint Savvas Anticancer Hospital trials
Trials by the same sponsor.
- NCT03654443 — Validation of the Critical-Care Pain Observation Tool (CPOT) in the Greek Population · NA · suspended
- NCT03260283 — Assessment of Subarachnoid Anesthesia With Low Dose of Pethidine and Combination of Ropivacaine With Fentanyl for Urolog · Phase 2, PHASE3 · completed
- NCT03232021 — Effect of Pregabalin Administration on Catheter- Related Bladder Discomfort in Orthopedic Surgical Operations · Phase 2, PHASE3 · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03229668 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Saint Savvas Anticancer Hospital
- Last refreshed: 31 March 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03229668.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing